BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 36 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,717 | -44.1% | 414,000 | -54.7% | 0.01% | -42.1% |
| Q2 2023 | $711,732 | -31.1% | 914,000 | -34.1% | 0.02% | -32.1% |
| Q1 2023 | $1,032,746 | +64.1% | 1,387,000 | 0.0% | 0.03% | +64.7% |
| Q4 2022 | $629,351 | -23.1% | 1,387,000 | 0.0% | 0.02% | -26.1% |
| Q3 2022 | $818,000 | +8.5% | 1,387,000 | 0.0% | 0.02% | +15.0% |
| Q2 2022 | $754,000 | -8.2% | 1,387,000 | 0.0% | 0.02% | +5.3% |
| Q1 2022 | $821,000 | -15.4% | 1,387,000 | +3.6% | 0.02% | -5.0% |
| Q4 2021 | $970,000 | -45.8% | 1,339,000 | +3.2% | 0.02% | -48.7% |
| Q3 2021 | $1,790,000 | -42.1% | 1,297,000 | -31.0% | 0.04% | -44.3% |
| Q2 2021 | $3,089,000 | -11.5% | 1,881,000 | -10.3% | 0.07% | -14.6% |
| Q1 2021 | $3,492,000 | – | 2,096,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |